Home > Insider Trading > Filing (0001209191-15-035520)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1517022	Akebia Therapeutics Inc.	AKBA	Pharmaceutical Preparations (2834)	208756903

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1315797	A Muneer Satter	C/O Akebia Therapeutics, Inc. 245 First Street, Suite 1100 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-22	420,000	$8.25	2,002,560	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Footnotes

These shares were purchased in the Issuer's public offering by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares.
The amount in Column 5 includes (a) 785,340 shares that are held by the Muneer A. Satter Revocable Trust for which the ReportingPerson serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares and (b) 1,217,220 shares thatare held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, insuch capacity, has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of allshares included in clause (b) of this footnote (2), except to the extent of his pecuniary interest.